Diagnos (TSXV:ADK) Buyback Yield % : -16.98 (As of Dec. 11, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Diagnos Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Diagnos's current buyback yield was -16.98%.

Diagnos Buyback Yield % Historical Data

The historical data trend for Diagnos's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnos Buyback Yield % Chart

Diagnos Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Buyback Yield %

Get a 7-Day Free Trial

-28.40

-3.05

-4.17

-9.08

Diagnos Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Buyback Yield %	Get a 7-Day Free Trial															-1.98	-8.46	-12.24	-20.58	-29.81

Competitive Comparison of Diagnos's Buyback Yield %

For the Health Information Services subindustry, Diagnos's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diagnos's Buyback Yield % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnos's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Diagnos's Buyback Yield % falls into.

Diagnos Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Diagnos's Buyback Yield for the fiscal year that ended in Mar. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	1.636)	/	18.012421
	=	-9.08%

Diagnos's annualized Buyback Yield for the quarter that ended in Sep. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (0	+	2.513)	*	4	/	33.7195875
	=	-29.81%

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Sep. 2024) data.

Diagnos Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Diagnos's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Diagnos Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnos Inc (TSXV:ADK) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

DGNOF:USA

Address

7005 Taschereau Boulevard, Suite 265, Brossard, Longueuil, QC, CAN, J4Z 1A7

Website

http://www.diagnos.ca

Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, Mexico, Chile, and others. The company's key revenue is derived from Canada.

Executives

Tristram Coffin	10% Security Holder
Marc-andré Massue	Senior Officer
Robert Dunn	Director
Francis Bellido	Director
Vincent Duhamel	Director
André Larente	Director, Senior Officer
Guillermo Moreno Robles	Senior Officer
Georges Hébert	Director
Gestion Maurice Pinsonnault Inc.	10% Security Holder

Diagnos Headlines

No Headlines